Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

154
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
154
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

189
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
189
Liver Physiology01:30

Liver Physiology

3.4K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.4K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

177
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
177

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The status and changing trend in the burden of refractive errors in China from 1990 to 2019].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2024
Same author

[Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2024
Same author

[To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2023
Same author

[Methods for controlling and evaluating residual confounding in the association analysis of observational study with a multicenter database].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2023
Same author

[Metal artifact reduction and clinical verification in oral and maxillofacial region based on deep learning].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2023
Same author

[Virtual reconstruction and clinical verification of maxillary defect based on deep learning].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2022
Same journal

[Transitional and clinical practice pathways for whole-course management of hepatocellular carcinoma in the infectious diseases department].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same journal

[Natural history and risk factors of metabolic associated fatty liver disease in Chinese cohorts].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same journal

[Analyzing research advances in single-cell sequencing technology for immunopathological mechanisms in acute-on-chronic liver failure].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same journal

[Advances in the diagnosis and treatment of patients with multidrug-resistant bacterial infections combined with severe liver disease].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same journal

[Dietary serine supplementation inhibits the hepatic macrophage AKT/mTOR pathway and improves primary biliary cholangitis].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
Same journal

[Clinical study on the efficacy of Wuling capsules combined with nucleos(t)ide analogues in the treatment of low-level viremia patients with chronic hepatitis B].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

30.8K

[Research progress on abnormal liver function in pregnancy].

Z W Wu1, X H Zheng2, J X Guo2

  • 1Department of Gynaecology and Obstetrics, Army Medical Center of PLA(Daping Hospital), Army Medical University, Chongqing 400010, China; Department of Women's Health, Maternal and Child Health and Family Planning Service Center, Yuzhong District, Chongqing 400010, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|October 10, 2019
PubMed
Summary
This summary is machine-generated.

Pregnancy-related liver diseases require accurate assessment for timely intervention. Comprehensive evaluation of mother and fetus ensures optimal treatment outcomes for abnormal liver function during pregnancy.

Keywords:
Liver disease in pregnancyLiver function testsPregnancy

More Related Videos

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases
06:21

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases

Published on: October 6, 2023

2.5K
Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
09:51

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Published on: January 27, 2023

2.1K

Related Experiment Videos

Last Updated: Jan 6, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

30.8K
Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases
06:21

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases

Published on: October 6, 2023

2.5K
Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
09:51

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Published on: January 27, 2023

2.1K

Area of Science:

  • Obstetrics and Gynecology
  • Hepatology
  • Maternal-Fetal Medicine

Background:

  • Abnormal liver function in pregnancy presents a significant clinical challenge.
  • Severe cases pose life-threatening risks to both mother and fetus.
  • Accurate diagnosis is crucial for effective management.

Purpose of the Study:

  • To emphasize the importance of accurate assessment of various causes of abnormal liver function in pregnancy.
  • To highlight the need for early intervention strategies.
  • To advocate for comprehensive maternal-fetal evaluation for optimal treatment.

Main Methods:

  • Clinical assessment of pregnant patients with abnormal liver function.
  • Differential diagnosis of pregnancy-related liver diseases.
  • Multidisciplinary evaluation of maternal and fetal status.

Main Results:

  • Accurate etiological assessment is vital for guiding timely interventions.
  • Comprehensive evaluation improves treatment efficacy.
  • Early detection and management reduce maternal and fetal risks.

Conclusions:

  • Prompt and accurate diagnosis of abnormal liver function in pregnancy is essential.
  • Integrated maternal-fetal assessment leads to better therapeutic results.
  • Management of pregnancy-related liver diseases requires a holistic approach.